Search Results - "MA, Qiufei"

Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data by Ma, Qiufei, Shilkrut, Mark, Zhao, Zhongyun, Li, Minming, Batty, Nicolas, Barber, Beth

“…Immunotherapies have advanced the treatment of metastatic melanoma; however, they are associated with immune-related toxicities. Patients with pre-existing…”
Get full text

Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey by Johnson, P Connor, Bailey, Abigail, Ma, Qiufei, Milloy, Neil, Butcher, Jake, Sanderson, Isaac, Weatherby, Sarah, Meadows, Rachael, Quek, Ruben G W

“…Real-world health-related quality of life (HRQoL) data in patients with diffuse large B-cell lymphoma (DLBCL) are scarce. This study is to compare…”
Get full text

From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population by Delea, Thomas E., Ma, Qiufei, Kroog, Glenn S., Ge, Wenzhen, Moynahan, Aaron, Sabater Anaya, Natalia, Rodriguez Lorenc, Karen, Song, Xue

“…Introduction Treatment of multiple myeloma (MM) has been transformed by novel therapies, including CD38 monoclonal antibodies (mAbs), immunomodulatory drugs…”
Get full text

Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma by Fowler, Nathan H, Chen, Guifang, Lim, Stephen, Manson, Stephanie, Ma, Qiufei, Li, Frank Yunfeng

“…Few studies have estimated the real-world economic burden such as all-cause and follicular lymphoma (FL)-related costs and health care resource utilization…”
Get full text

HIV Screening in Commercially Insured Patients Screened or Diagnosed With Sexually Transmitted Diseases or Blood-Borne Pathogens by Chen, Judy Ying, Ma, Qiufei, Everhard, Francois, Yermilov, Irina, Tian, Haijun, Mayer, Kenneth Hugh

“…Background: The Centers for Disease Control strongly recommends HIV screening for all patients who present to health care settings with sexually transmitted…”
Get full text

PB2090: SYSTEMATIC LITERATURE REVIEW OF PROGNOSTIC FACTORS FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA by Kumar, Shaji, Leleu, Xavier, Weisel, Katja, Popat, Rakesh, Craigie, Samantha, Patel, Leena, Ramirez, Abril Oliva, Ge, Wenzhen, MA, Qiufei, Hampp, Christian, Jagannath, Sundar

Get full text

PB2357: TRIAL IN PROGRESS: OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH SYSTEMIC THERAPY FROM REAL‐WORLD EXPERIENCE (ORCHID) by Thieblemont, Catherine, MA, Qiufei, Hampp, Christian, Harnett, James, Sobel, Rachel E, Jalbert, Jessica J, Quek, Ruben Gw, Wei, Wenhui, Wu, Ning, Mastey, Vera, Wang, Joy, Bajwa, Anit, Maissenhaelter, Benedikt, Gils, Chantal, Aggarwal, Shivani, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Bachy, Emmanuel, Damaj, Gandhi Laurent

Get full text

PB2281: TRIAL IN PROGRESS: FOLLICULAR LYMPHOMA OUTCOMES IN RELAPSED/REFRACTORY PATIENTS TREATED WITH SYSTEMIC THERAPY IN A REAL‐WORLD ASSESSMENT (FLORA) by Damaj, Gandhi Laurent, Bachy, Emmanuel, MA, Qiufei, Hampp, Christian, Harnett, James, Sobel, Rachel E, Jalbert, Jessica J, Quek, Ruben Gw, Wei, Wenhui, Wu, Ning, Mastey, Vera, Wang, Joy, Bajwa, Anit, Maissenhaelter, Benedikt, Gils, Chantal, Aggarwal, Shivani, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Thieblemont, Catherine

Get full text

A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible? by Zhang, Jie, Li, Junlong, Ma, Qiufei, Yang, Hongbo, Signorovitch, James, Wu, Eric

“…Anti-CD19 chimeric antigen receptor (CAR) T-cell therapies can be effective for diffuse large B-cell lymphoma (DLBCL), a cancer with limited treatment options…”
Get full text

Real-World Study of Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma: Analysis across a Spectrum of Advanced Disease Stage Medicare Patients in the United States by Delea, Thomas, Moynahan, Aaron, Ge, Wenzhen, Song, Xue, Kroog, Glenn S., Noguera-Troise, Irene, Rodriguez Lorenc, Karen, Ma, Qiufei

“…Background Treatment of relapsed/refractory (RR) multiple myeloma (MM) has been transformed by novel therapies including anti-CD38 monoclonal antibodies (mAb),…”
Get full text

Real-World Health-Related Quality of Life in Patients with Diffuse Large B-Cell Lymphoma: Comparisons with Reference Populations and By Line of Therapy by Ma, Qiufei, Bailey, Abigail, Milloy, Neil, Butcher, Jake, Quek, Ruben G.W, Johnson, Patrick Connor

“…Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most common type of aggressive non-Hodgkin's lymphoma (NHL) constituting 30-58% of all NHL (Tilly et…”
Get full text

Treatment Preferences Among Patients with Diffuse Large B-Cell Lymphoma: A Survey across Western Europe and the United States of America by Johnson, Patrick Connor, Quek, Ruben G.W, Bailey, Abigail, Milloy, Neil, Sanderson, Isaac, Ma, Qiufei

“…Introduction: Diffuse large B-cell lymphoma (DLBCL) is an aggressive form of non-Hodgkin's lymphoma (NHL), encompassing 30-58% of all NHL cases and…”
Get full text

Healthcare resource use (HRU) by infusion setting of chimeric antigen receptor T-cell (CAR-T) in patients with relapsed and refractory (r/r) diffuse large B-cell lymphoma (DLBCL): A retrospective cohort study using CMS 100% Medicare database by Zhao, Jing, Bollu, Vamsi, Yang, Hongbo, Dalal, Anand, Tesfaye, Mimi, Ma, Qiufei, Lax, Angela, Lim, Stephen

“…Abstract only e19550 Background: Axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) are CAR-T therapies that were approved for r/r DLBCL in 2017…”
Get full text

Key Prognostic Factors in Patients with Relapsed/Refractory Follicular Lymphoma: An Evidence Based Systematic Literature and Medical Review by Jimenez Ubieto, Ana, Costa, Pau Abrisqueta, Hampp, Christian, Aggarwal, Shivani, Shah, Mohsin, Walsh, Laura, Thorley, Eileen, Ma, Qiufei, von Tresckow, Bastian

“…Introduction: A multi-center multi-country retrospective cohort study (FLORA [NCT05338879]), using real-world data (RWD) from electronic medical records (EMRs)…”
Get full text

Incidence of Second Primary Malignancies in Medicare-Insured Patients in the US with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma by Ailawadhi, Sikander, Delea, Thomas, Moynahan, Aaron, Ge, Wenzhen, Hampp, Christian, Archambault, Alexi, Wu, Ning, Rodriguez Lorenc, Karen, Noguera-Troise, Irene, Kroog, Glenn S., Houvras, Yariv, Ma, Qiufei

“…Background As therapeutic advances have increased life expectancy for patients (pts) with relapsed/refractory (RR) multiple myeloma (MM), second primary…”
Get full text

Key Prognostic Factors in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: An Evidence Based Systematic Literature and Medical Review by von Tresckow, Bastian, Costa, Pau Abrisqueta, Aggarwal, Shivani, Hampp, Christian, Walsh, Laura, Thorley, Eileen, Shah, Mohsin, Ma, Qiufei, Jimenez Ubieto, Ana

“…Introduction: A multi-center multi-country retrospective cohort study (ORCHID [NCT05338879]), using real-world data (RWD) from electronic medical records…”
Get full text

Identification and Characterization of Fusarium proliferatum, a New Species of Fungi that Cause Fungal Keratitis by Sun, Shengtao, Lui, Qixue, Han, Lei, Ma, Qiufei, He, Siyu, Li, Xiaohua, Zhang, Hongmin, Zhang, Junjie, Liu, Xiaohui, Wang, Liya

“…Fusarium proliferatum ( F. proliferatum ) is known as a pathogen of corn and other crops, but its role in fungal keratitis has not been well investigated…”
Get full text

Real-World Study of Patients with Triple-Class Exposed Relapsed or Refractory Multiple Myeloma: Analysis across a Spectrum of Advanced Disease Stage Patients in the United States by Ma, Qiufei, Song, Xue, Delea, Thomas E., Kroog, Glenn S., Ge, Wenzhen, Chi, Lei, Moynahan, Aaron, Weycker, Derek, Rodriguez Lorenc, Karen

Get full text

Incidence of Second Primary Malignancies (SPMs) in Patients in the US with Triple-Class-Exposed (TCE) Relapsed or Refractory Multiple Myeloma (RRMM) by Ge, Wenzhen, Archambault, Alexi, Delea, Thomas E., Rodriguez Lorenc, Karen, Harnett, James, Moynahan, Aaron, Weycker, Derek, Houvras, Yariv, Kroog, Glenn S., Wu, Ning, Hampp, Christian, Ma, Qiufei

Get full text

From triple-class exposed (TCE) to penta-exposed and triple-class refractory (PE-TCR): Real-world outcomes across a spectrum of advanced relapsed or refractory multiple myeloma (RRMM) patients (Pts) in the United States by Delea, Thomas E., Song, Xue, Ge, Wenzhen, Chi, Lei, Eichten, Caitlin, Moynahan, Aaron, Weycker, Derek, Ma, Qiufei, Kroog, Glenn Scott, Rodriguez-Lorenc, Karen

“…e20011 Background: RRMM treatment (Tx) has been transformed by novel Txs including anti-CD38 monoclonal antibodies (mAbs) and 2 nd /3 rd generation…”
Get full text